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Introduction
FMF is an ethnically restricted disease for ancestors
from Mediterranean sea region and it has high preva-
lence in Armenia as well. Neurologic manifestations in
children with FMF are relatively uncommon. Headaches
occur frequently in FMF and have mainly migraine-like
nature. Aseptic meningitis and convulsive disorders as
well have been reported.
Objectives
To study the epilepsy in Armenian children with FMF.
Methods
We observed 2300 patients with FMF (1408 boys and
892 girls; mean age: 8.86±0.29) in the National Pedia-
tric Centre for FMF. Diagnosis of FMF was based on
Tel-Hashomer criteria and MEFV genetic analysis. The
epilepsy was diagnosed based on clinical manifestations
(>2 unprovoked epileptic seizures),neurological history,
exam, EEG and MRI. The statistical analysis was per-
formed using Epi-Info 2000 software.
Results
Epilepsy was diagnosed in 12 (0.5%) FMF patients (5 boys
and 7 girls; aged from 7 to 18 years). The frequency of the
epilepsy was not exceed the average indices for a healthy
Armenian population (0.6%). The mean age of FMF mani-
festation was 3.5 years and the same indices for epilepsy
onset made 7.5 years. Family history on FMF and epilepsy
was observed in 9 and 6 patients respectively.
FMF with moderate activity was diagnosed in most (8)
patients. Four patients with severe course of FMF had
acute recurrent arthritis. At that the following mutations
of MEFV were detected: 694V/M694V (4 patients);
M694V/V726A (3 patients) and by each one of M694V/
R764H, M694V/E148Q, V726A/M680I, M694V/0,
E148Q/0 (in total - 5 patients).High penetrance M694V
mutation was determined in 5 patients, mainly with
severe homozygous genotype (4 patients). Colchicine
therapy was effective for 7 patients. Partial epilepsy with
secondary generalized and/or complex partial seizures
was diagnosed in 6 FMF patients. Four had primary
generalized epilepsy with frequent polymorphic convul-
sions. Symptomatic epilepsy with polymorphic partial
fits had two FMF patients with cerebral palsy. Idiopathic
generalized epilepsy with photosensitive absences was in
one case. In 7 FMF children epilepsy was diagnosed
after manifestation of FMF and they were responsive to
antiepileptic treatment. In 5 patients convulsive disorder
precede the diagnosis of FMF. In these cases, convul-
sions were resistant to antiepileptic drugs alone and
they subsided only when colchicine was added.
Conclusion
Taking into account, that epilepsy is a genetically deter-
minate disorder and the majority of FMF patients with
epilepsy were carriers of M694V mutation and severe
homozygous genotype, it is not excluded, that the com-
bination of FMF with certain type of convulsive disor-
ders/epilepsy (probably based on some vascular lesions)
might be possible in the presence of similar environ-
mental and social triggers. However, we suppose that
the low frequency of epilepsy (0.5%) among Armenian
children with FMF, which does not exceed the fre-
quency for general healthy population, as well as the
positive response of these patients to both colchicine
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